Improving the Care Pathway for Patients with Idiopathic Pulmonary Fibrosis

Maeve Cahill
Idiopathic Pulmonary Fibrosis (IPF) is a progressive life-limiting interstitial lung disease. The median survival from diagnosis is just three years and the clinical course of the disease is highly variable. Due to the short course of this condition, early diagnosis and intervention is vital to improve patient outcomes and quality of care. Management of IPF is multi-factorial and requires the introduction of a standardised IPF care pathway and service to improve patient care. Increasing all...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.